Related Experiment Video
Updated: Jul 5, 2025

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
Published on: April 18, 2025
Type 2 cytokine signaling in macrophages protects from cellular senescence and organismal aging
Zhao Zhou1, Jingfei Yao1, Dongmei Wu2
1Institute of Molecular Medicine, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, College of Future Technology, Peking University, Beijing 100871, China.
Abstract:
Accumulation of senescent cells in organs and tissues is a hallmark of aging and known to contribute to age-related diseases. Although aging-associated immune dysfunction, or immunosenescence, is known to contribute to this process, the underlying mechanism remains elusive. Here, we report that type 2 cytokine signaling deficiency accelerated aging and, conversely, that the interleukin-4 (IL-4)-STAT6 pathway protected macrophages from senescence. Mechanistically, activated STAT6 promoted the expression of genes involved in DNA repair both via homologous recombination and Fanconi anemia pathways. Conversely, STAT6 deficiency induced release of nuclear DNA into the cytoplasm to promote tissue inflammation and organismal aging. Importantly, we demonstrate that IL-4 treatment prevented macrophage senescence and improved the health span of aged mice to an extent comparable to senolytic treatment, with further additive effects when combined. Together, our findings support that type 2 cytokine signaling protects macrophages from immunosenescence and thus hold therapeutic potential for improving healthy aging.
Insights
Type 2 cytokine signaling, specifically the interleukin-4 (IL-4)-STAT6 pathway, protects macrophages from aging and senescence. This discovery offers potential therapeutic strategies for enhancing healthy aging and combating age-related diseases.
Area of Science:
- Immunology
- Cellular Biology
- Gerontology
Background:
- Cellular senescence is a hallmark of aging, contributing to age-related diseases.
- Aging-associated immune dysfunction (immunosenescence) plays a role, but mechanisms are unclear.
Purpose of the Study:
- To investigate the role of type 2 cytokine signaling in macrophage senescence and aging.
- To elucidate the protective mechanisms of the interleukin-4 (IL-4)-STAT6 pathway.
Main Methods:
- Investigated the effects of type 2 cytokine signaling deficiency on aging.
- Examined the impact of the IL-4-STAT6 pathway on macrophage senescence.
- Assessed STAT6's role in DNA repair gene expression and nuclear DNA release.
- Evaluated IL-4 treatment in aged mice models.
Main Results:
- Deficiency in type 2 cytokine signaling accelerated aging.
- The IL-4-STAT6 pathway protected macrophages from senescence.
- Activated STAT6 enhanced DNA repair gene expression.
- STAT6 deficiency led to cytoplasmic nuclear DNA release, promoting inflammation and aging.
- IL-4 treatment prevented macrophage senescence and improved health span in aged mice, with additive effects when combined with senolytics.
Conclusions:
- Type 2 cytokine signaling protects macrophages from immunosenescence.
- The IL-4-STAT6 pathway is a key regulator of macrophage aging.
- Targeting this pathway holds therapeutic potential for improving healthy aging and treating age-related conditions.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...

